Misonix Announces Inclusion in the Russell 2000® and 3000 Indexes
01 July 2019 - 9:30PM
Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a
provider of minimally invasive therapeutic ultrasonic medical
devices that enhance clinical outcomes, today announced that it has
been selected to be added to the broad-market Russell 2000 and
3000® Indexes as part of the annual reconstitution of the Russell
stock indexes. The Russell index changes became effective at the
market close on June 28, 2019. Misonix is already included in
the Russell MicroCap Index.
“We are very pleased to be added to the Russell
2000 and 3000 Indexes,” stated Stavros Vizirgianakis, President and
Chief Executive Officer of Misonix. “A little over two years ago,
we embarked on a new company-wide strategy to significantly grow
and improve the business to become the standard of care in our
addressable markets. In this short period of time, we have
transformed Misonix from an under-appreciated company with
valuable, yet ineffectively monetized, proprietary technology, into
a world class organization with high margin revenue streams growing
in excess of 20%. Following the recent announcements related to our
proposed acquisition of Solsys and the US FDA clearance for our new
Nexus product, our inclusion on the Russell indices marks yet
another important milestone for Misonix and represents an
opportunity to further increase our visibility and exposure among a
broader and growing group of institutional investors.”
Annual Russell indexes reconstitution captures
the 4,000 largest US stocks as of May 10, ranking them by total
market capitalization. Membership in the US all-cap Russell 3000®
Index means automatic inclusion in the large-cap Russell 1000®
Index or small-cap Russell 2000® Index, as well as the appropriate
growth and value style indexes. Membership in the US all-cap
Russell 3000® Index and the Russell Microcap® Index remain in place
for one year. FTSE Russell determines membership for its Russell
indexes primarily by objective, market-capitalization rankings and
style attributes.
Russell indexes are widely used by investment
managers and institutional investors for index funds and as
benchmarks for active investment strategies. Approximately $9
trillion in assets are benchmarked against Russell’s US indexes.
Russell indexes are part of FTSE Russell, a leading global index
provider.
About Misonix, Inc.Misonix, Inc. (NASDAQ: MSON)
designs, manufactures and markets ultrasonic medical devices for
the precise removal of hard and soft tissue, including bone
removal, wound debridement and ultrasonic aspiration. Misonix is
focused on leveraging its proprietary ultrasonic technology to
become the standard of care in operating rooms and clinics around
the world. Misonix's proprietary ultrasonic medical devices are
used in a growing number of medical procedures, including spine
surgery, neurosurgery, orthopedic surgery, cosmetic surgery,
laparoscopic surgery, and other surgical and medical applications.
At Misonix, Better Matters to us. That is why throughout the
Company’s history, Misonix has maintained its commitment to medical
technology innovation and the development of ultrasonic surgical
products that radically improve patient outcomes. Additional
information is available on the Company's web site at
www.misonix.com.
About FTSE Russell FTSE Russell
is a global index leader that provides innovative benchmarking,
analytics and data solutions for investors worldwide. FTSE Russell
calculates thousands of indexes that measure and benchmark markets
and asset classes in more than 70 countries, covering 98% of the
investable market globally. FTSE Russell index expertise and
products are used extensively by institutional and retail investors
globally. Approximately $16 trillion is currently benchmarked to
FTSE Russell indexes. For over 30 years, leading asset owners,
asset managers, ETF providers and investment banks have chosen FTSE
Russell indexes to benchmark their investment performance and
create ETFs, structured products and index-based derivatives. A
core set of universal principles guides FTSE Russell index design
and management: a transparent rules-based methodology is informed
by independent committees of leading market participants. FTSE
Russell is focused on applying the highest industry standards in
index design and governance and embraces the IOSCO Principles. FTSE
Russell is also focused on index innovation and customer
partnerships as it seeks to enhance the breadth, depth and reach of
its offering. FTSE Russell is wholly owned by London Stock Exchange
Group. For more information, visit www.ftserussell.com
Contact: |
|
|
Joe Dwyer |
|
Norberto Aja, Jennifer
Neuman |
Chief Financial Officer |
|
JCIR |
Misonix, Inc. |
|
212-835-8500 or
mson@jcir.com |
631-927-9113 |
|
|
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Apr 2024 to May 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From May 2023 to May 2024